TCT 983: A Novel TTVR System for Tricuspid Regurgitation: 2 Year Follow-up of the Early Compassionate Use Experience

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker’s Bureau - Edwards Lifesciences</li><li>Grant Support/Research Contract - Edwards Lifesciences</li></ul>